Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT05026632 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

NPI-002 Intravitreal Implant for the Delay of Cataract Progression

StatusCompleted
PhasePhase 1/2
Started
View on ClinicalTrials.gov ↗

Record History

See every version on ClinicalTrials.gov ↗

  1. Trial completed
    • Final enrollment: 24 participants (planned 30)
    • Primary and study completion dates changed from estimate of Sep 2026 to Sep 3, 2026
    • Eligibility criteria expanded, about 14 words
  2. Trial status: Recruiting to Active, Not Recruiting
    • Primary and study completion dates: Apr 2026 to Sep 2026
    • Site details revised
    v8
  3. Primary completion date: Oct 2025 to Apr 2026
    • Study completion date: Dec 2025 to Apr 2026
    v7
  4. Primary completion date: Oct 2024 to Oct 2025
    • Study completion date: Feb 2025 to Dec 2025
    v6
  5. Primary completion date: Dec 2023 to Oct 2024
    • Study completion date: Apr 2024 to Feb 2025
    v5
Show 3 earlier versionsHide 3 earlier versions
  1. Primary completion date: Sep 2023 to Dec 2023
    • Study completion date: Dec 2023 to Apr 2024
    v4
  2. Primary completion date: Dec 2022 to Sep 2023
    • Study completion date: Feb 2023 to Dec 2023
    • Eligibility criteria expanded, about 3 words
    v3
  3. Trial status: Not Yet Recruiting to Recruitingv2 Show 4 more changesShow less
    • Study sites: 0 to 1
    • Primary completion date: Jul 2022 to Dec 2022
    • Study completion date: Sep 2022 to Feb 2023
    • Start date changed from estimate of Oct 2021 to Jan 27, 2022
  1. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
This study will examine the safety and efficacy NPI-002 intravitreal implants post vitrectomy.
Trial Details
NCT Number NCT05026632
Lead Sponsor Nacuity Pharmaceuticals, Inc.
Conditions
(from sponsor)		 Cataract
Related terms Cataract
Enrollment 24 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov